WebDyne Therapeutics (DYN) has a Smart Score of 7 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund Activity. ... Market Cap. $495.76M. Enterprise Value $263.49M. Total Cash (Recent Filing) $256.01M. Total Debt (Recent Filing) $30.48M. Price to Earnings (P/E)-2.7. Beta 0.93. Next … WebDyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle ...
DYN - Dyne Therapeutics, Inc. Stock Price and Quote - FINVIZ.com
WebApr 12, 2024 · Market Cap Chart Since the IPO on September 17, 2024, Dyne Therapeutics, Inc.'s market cap has decreased from $790.90M to $480.56M, a decrease of -39.24%. That is a compound annual growth rate of -17.66%. WebApr 10, 2024 · Dyne Therapeutics Inc. company and executive profile by Barron's. View the latest DYN company infomation and executive bios. ireland ccj
DYN : Dyne Therapeutics Inc - MSN Money
WebDYN (Dyne Therapeutics) Market Cap as of today (January 08, 2024) is $606.76 Mil. Market Cap explanation, calculation, historical data and more DYN (Dyne … WebFeb 28, 2024 · Latest Dyne Therapeutics Inc Stock News. As of February 28, 2024, Dyne Therapeutics Inc had a $681.8 million market capitalization, putting it in the 59th percentile of companies in the Biotechnology & Medical Research industry. Dyne Therapeutics Inc does not have a meaningful P/E due to negative earnings over the last … ireland ccyb